PharVision Advisers’s Herc Holdings HRI Stock Holding History

PharVision Advisers’s Portfolio HRI Stock Details HRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,524	Closed	-$226K	–	352
2025 Q4	$226K	Buy	+1,524	New	+$209K	0.11%	459

Other funds holding HRI

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CCM

Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

PharVision Advisers's HRI Position: Q1 2026 in Review

PharVision Advisers sold out of Herc Holdings (HRI) in Q1 2026, closing a stake of 1,524 shares — an estimated $226K sold.

PharVision Advisers first reported a position in HRI in Q4 2025 and held it in 1 quarter. The position peaked at $226K in Q4 2025. 304 funds tracked by Wall St. Rank hold HRI as of Q1 2026.

PharVision Advisers reported no remaining Herc Holdings position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 1,524 Herc Holdings shares in Q1 2026, an estimated $226K.
PharVision Advisers first reported a position in Herc Holdings in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Herc Holdings position peaked at $226K in Q4 2025.
304 funds tracked by Wall St. Rank held Herc Holdings as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.